Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Harnessing DNA for immunotherapy: Cancer, infectious diseases, and beyond. | Adv Funct Mater | 2022 | 36304724 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies. | Dis Markers | 2022 | 36304254 | PubTator, text mining | PubMed |
| The impact of Epstein-Barr virus latent membrane protein 2A on the production of B cell activating factor of the tumor necrosis factor family (BAFF), APRIL and their receptors. | Immun Inflamm Dis | 2022 | 36301035 | PubTator, text mining | PubMed |
| Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients. | Front Immunol | 2022 | 36300104 | PubTator, text mining | PubMed |
| Prognostic significance and identification of basement membrane-associated lncRNA in bladder cancer. | Front Oncol | 2022 | 36300088 | PubTator, text mining | PubMed |
| Combating challenges in CAR-T cells with engineering immunology. | Front Cell Dev Biol | 2022 | 36299480 | PubTator, text mining | PubMed |
| Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene Transfer. | Viruses | 2022 | 36298713 | PubTator, text mining | PubMed |
| Allergic Rhinitis: Pathophysiology and Treatment Focusing on Mast Cells. | Biomedicines | 2022 | 36289748 | PubTator, text mining | PubMed |
| Widely applicable, extended flow cytometric stem cell enumeration panel for quality control of advanced cellular products. | Sci Rep | 2022 | 36289245 | PubTator, text mining | PubMed |
| Multiplexed imaging mass cytometry reveals distinct tumor-immune microenvironments linked to immunotherapy responses in melanoma. | Commun Med (Lond) | 2022 | 36281356 | PubTator, text mining | PubMed |
| A lactate-related LncRNA model for predicting prognosis, immune landscape and therapeutic response in breast cancer. | Front Genet | 2022 | 36276952 | PubTator, text mining | PubMed |
| A multifaceted and feasible prognostic model of amino acid metabolism-related genes in the immune response and tumor microenvironment of head and neck squamous cell carcinomas. | Front Oncol | 2022 | 36276126 | PubTator, text mining | PubMed |
| Application of genomic selection and experimental techniques to predict cell death and immunotherapeutic efficacy of ferroptosis-related CXCL2 in hepatocellular carcinoma. | Front Oncol | 2022 | 36276119 | PubTator, text mining | PubMed |
| Costimulators expressed on human endothelial cells modulate antigen-dependent recruitment of circulating T lymphocytes. | Front Immunol | 2022 | 36275645 | PubTator, text mining | PubMed |
| Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration. | J Inflamm Res | 2022 | 36274829 | PubTator, text mining | PubMed |
| Identification of fatty acid signature to predict prognosis and guide clinical therapy in patients with ovarian cancer. | Front Oncol | 2022 | 36267966 | PubTator, text mining | PubMed |
| A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma. | Front Genet | 2022 | 36267408 | PubTator, text mining | PubMed |
| Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma. | PLoS One | 2022 | 36264920 | PubTator, text mining | PubMed |
| Prognostic Signature GXYLT2 Is Correlated with Immune Infiltration in Bladder Cancer. | Dis Markers | 2022 | 36263004 | PubTator, text mining | PubMed |
| Acute undifferentiated leukemia limited to neck lymph nodes and a large mediastinal mass. | J Clin Exp Hematop | 2022 | 36261335 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=36